title: Murine model for skeletal metastases of Ewing's sarcoma.
abstract: Ewing's sarcoma shows a strong tendency to metastasize to the lungs or the skeleton, or both. A peculiar feature of the secondary involvement of bone with this tumor is that it may also appear in the absence of clinically evident lung metastases, both at clinical presentation and during the course of the disease. Although osseous metastases are critically relevant for prognosis, the pathogenesis of this peculiar feature of Ewing's sarcoma is poorly understood, partly due to the lack of appropriate experimental in vivo models. We show that the intravenous injection of TC-71 Ewing's sarcoma cells into athymic 4-5-week-old Crl/nu/nu (CD1) BR mice reproducibly colonizes specific sites of the skeleton in addition to the lungs and lymph nodes. The distribution and the morphologic appearance of these experimental bone metastases mimic the pattern of skeletal involvement observed in humans. This experimental model of bone metastasis of Ewing's sarcoma may be the basis for future studies aimed at understanding the pathophysiology and treatment of Ewing's sarcoma.
authors.affiliation: Laboratorio di Ricerca Oncologica, Istituti Ortopedici Rizzoli, Università degli Studi di Bologna, Italy. katia.scotlandi@ior.it
authors.forename: K
authors.initials: K
authors.lastname: Scotlandi
authors.forename: S
authors.initials: S
authors.lastname: Benini
authors.forename: M C
authors.initials: MC
authors.lastname: Manara
authors.forename: M
authors.initials: M
authors.lastname: Serra
authors.forename: P
authors.initials: P
authors.lastname: Nanni
authors.forename: P L
authors.initials: PL
authors.lastname: Lollini
authors.forename: G
authors.initials: G
authors.lastname: Nicoletti
authors.forename: L
authors.initials: L
authors.lastname: Landuzzi
authors.forename: T
authors.initials: T
authors.lastname: Chano
authors.forename: P
authors.initials: P
authors.lastname: Picci
authors.forename: N
authors.initials: N
authors.lastname: Baldini
mesh_terms: D000071443:12E7 Antigen; D000818:Animals; D015703:Antigens, CD / Q000378:metabolism; D001859:Bone Neoplasms / Q000378:metabolism / Q000556:secondary*; D015815:Cell Adhesion Molecules / Q000378:metabolism; D004195:Disease Models, Animal; D005260:Female; D006003:Glycogen / Q000378:metabolism; D016023:Integrins / Q000378:metabolism; D008175:Lung Neoplasms / Q000556:secondary; D020782:Matrix Metalloproteinases / Q000378:metabolism; D051379:Mice; D008819:Mice, Nude / Q000378:metabolism; D009362:Neoplasm Metastasis / Q000503:physiopathology*; D017978:Receptors, Growth Factor / Q000378:metabolism; D012512:Sarcoma, Ewing / Q000378:metabolism / Q000556:secondary*; D019715:Tissue Inhibitor of Metalloproteinase-1 / Q000378:metabolism; D019716:Tissue Inhibitor of Metalloproteinase-2 / Q000378:metabolism; D014407:Tumor Cells, Cultured / Q000378:metabolism / Q000473:pathology
chemical_list: D000071443:12E7 Antigen; D015703:Antigens, CD; C061828:CD99 protein, human; D015815:Cell Adhesion Molecules; D016023:Integrins; D017978:Receptors, Growth Factor; D019715:Tissue Inhibitor of Metalloproteinase-1; D019716:Tissue Inhibitor of Metalloproteinase-2; D006003:Glycogen; D020782:Matrix Metalloproteinases